Aspira Women’s Health Reports First Quarter 2024 Financial Results
Q1 2024 OvaSuiteSMrevenue of $2.2 million and volume of 5,829 units Q1 2024 cash utilization of $4.4 million, a decrease […]
AppTech Payments Corp. Reports Strong Start to 2024 with Positive First Quarter Financial Results and Strategic Business Advances
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) — AppTech Payments Corp. (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce, […]
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Global pivotal Phase 3 clinical trial would be conducted jointly by Verrica and Torii Pharmaceutical; trial expected to begin in […]
LeddarTech Reports F2Q24 Results
QUEBEC CITY, Canada, May 15, 2024 (GLOBE NEWSWIRE) — LeddarTech Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that […]
M&T Bank Expands Use of nCino with Adoption of Continuous Credit Monitoring Solution Powered by Rich Data Co’s Explainable AI Platform
WILMINGTON, N.C., May 15, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global […]
Bread Financial™ Provides Performance Update for April 2024
COLUMBUS, Ohio, May 15, 2024 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides […]
Groupe Prime Drink Corp. conclut une entente définitive pour l’acquisition de Triani Canada inc.
MONTRÉAL, 15 mai 2024 (GLOBE NEWSWIRE) — Groupe Prime Drink Corp. (CSE : PRME) (« Prime » ou la « Société ») annonce […]
Prime Drink Group Corp. Enters Into Definitive Agreement to Acquire Triani Canada Inc.
MONTREAL, May 15, 2024 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE:PRME) (“Prime” or the “Company”) announces that it has […]
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations related to […]
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, extending expected cash runway into […]
